High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis.

Xue, Hong-Xia; Fu, Wen-Yi; Cui, Hua-Dong; Yang, Li-Li; Zhang, Ning; Zhao, Li-Juan

Xue, Hong-Xia; Fu, Wen-Yi; Cui, Hua-Dong; Yang, Li-Li; Zhang, Ning; Zhao, Li-Juan.

Afiliação

Xue HX; Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Fu WY; Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Cui HD; Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Yang LL; Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Zhang N; Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Zhao LJ; Department of Rheumatology and Immunology, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China.

Neural Regen Res ; 10(5): 814-8, 2015 May.

Article em En | MEDLINE | ID: mdl-26109960

Palavras-chave

adverse reactions; age; ankylosing spondylitis; dose; nerve regeneration; neural regeneration; peripheral nerve injury; peripheral neuropathy; prospective study; sex; thalidomide; treatment; treatment time

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Neural Regen Res Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google